District court upholds herbal extract patents
This article was originally published in The Tan Sheet
Executive Summary
Herbal extract firm Sabinsa Corp. retains exclusive proprietary rights to BioPerine (piperine black pepper extract) and Forslean (coleus forkskohlii), the U.S. District Court for the District of New Jersey says in a June 27 final judgment against DNP International. The ruling upholds the validity and enforceability of the '382, '596 and '712 patents pertaining to Sabinsa's products. DNP agreed to discontinue importing, manufacturing and/or marketing piperine, coleus and coleus oil for sale in the United States. Sabinsa sued DNP for patent infringement because it marketed and distributed piperine and coleus for uses previously researched and patented by Sabinsa in the late 1960s, the company says. Piscataway, N.J.-based Sabinsa manufactures Phytonutrients and Ayurvedic herbal extracts for nutritional, pharmaceutical and food products...
You may also be interested in...
Sabinsa's ForsLean protected
Sabinsa prevails with an appellate court ruling that Creative Compounds' Forsthin brand infringed on the nutritional supplement ingredient supplier's ForsLean trademark. The East Windsor, N.J., firm said July 14 the Third Circuit U.S. Court of Appeals reversed a federal district court judgment in favor of Creative Compounds and ordered a judgment entered in favor of Sabinsa without a new trial. According to the ruling, Sabinsa first marketed ForsLean (coleus forskohlii) to manufacturers in 2000 as an ingredient to promote lean body mass and later created pamphlets marketing the ingredient directly to consumers. Scott City, Mo.-based Creative Compounds began selling its forskohlin product in 2002, but did not adopt the brand Forsthin until the spring of 2004, prompting a cease-and-desist letter from Sabinsa. Sabinsa in 2007 retained exclusive U.S. proprietary rights to ForsLean with a U.S. district court patent infringement judgment against DNP International (1"The Tan Sheet" July 9, 2007, In Brief)
Sabinsa adds Canadian patent
The Piscataway, N.J.-based dietary supplement manufacturer on Aug. 6 says it has added a patent from Canada to its U.S., European and Japanese patents protecting its Bioperine branded ingredient, which is derived from piperine black pepper extract, for use as a bioavailability enhancer. The firm says Bioperine is the only piperine that can legally be used in Canada to enhance the bioavailability of nutrients in supplement products. Sabinsa retained exclusive U.S. proprietary rights to its BioPerine and Forslean (coleus forkskohlii) ingredients in June with a final judgment by the U.S. District Court for the District of New Jersey against DNP International, which Sabinsa sued for patent infringement because it marketed and distributed piperine and coleus for uses previously researched and patented by Sabinsa in the late 1960s (1"The Tan Sheet" July 9, 2007, In Brief)...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.